**Core Concept**
The question tests the student's knowledge of antipsychotic drugs, specifically their pharmacological profiles, side effects, and receptor affinities. This involves understanding the differences between various antipsychotic agents, their actions on serotonin receptors, and their potential risks.

**Why the Correct Answer is Right**
Ziprasidone has a high affinity for 5-HT2 receptors in the brain, which contributes to its antipsychotic effects. Unlike some other antipsychotics, ziprasidone does not cause significant extrapyramidal dysfunction (such as parkinsonism or dystonia), which is a common side effect of typical antipsychotics. Additionally, ziprasidone is known to have a lower risk of hematotoxicity (affecting blood cells) compared to clozapine. However, it is associated with a higher risk of QT prolongation, a condition that can increase the risk of serious cardiac arrhythmias.

**Why Each Wrong Option is Incorrect**
**Option A:** Chlorpromazine is a typical antipsychotic with a lower affinity for 5-HT2 receptors and a higher risk of extrapyramidal dysfunction and hematotoxicity.
**Option B:** Clozapine has a high affinity for 5-HT2 receptors but is associated with a significant risk of hematotoxicity, making it an incorrect choice.
**Option C:** Olanzapine has a high affinity for 5-HT2 receptors but can cause extrapyramidal dysfunction, particularly at higher doses, and is not as strongly associated with QT prolongation as ziprasidone.

**Clinical Pearl / High-Yield Fact**
When selecting an antipsychotic, it's essential to consider the patient's risk factors for QT prolongation, such as a history of cardiac disease or concomitant use of medications that prolong the QT interval. Monitoring of cardiac function and regular ECGs may be necessary when using ziprasidone or other antipsychotics with this risk.

**✓ Correct Answer: D. Ziprasidone**